clinical data from the phase iii prima trial
Published 4 years ago • 115 plays • Length 4:06Download video MP4
Download video MP3
Similar videos
-
9:22
gynonc paper review: prima
-
4:45
how do clinical trials work for ovarian cancer? what is the process?
-
1:34
dr. gonzalez-martin on the impact of the prima trial in advanced ovarian cancer
-
1:12
data demonstrate efficacy of 3 parp inhibitors in ovarian cancer
-
1:03:39
precision medicine in ovarian cancer with parp inhibitor therapy and companion diagnostics
-
17:16
parp inhibitors and ovarian cancer | memorial sloan kettering
-
1:19:47
ovarian cancer: parp inhibitors and beyond (webinar) may 8th world ovarian cancer day
-
1:50
niraparib shows positive data, requires different dosing in ovarian cancer
-
5:37
maintenance therapy: nccn guidelines, paola-1 trial
-
3:26
niraparib monotherapy in late-line ovarian cancer
-
8:16
pivotal trials in the realm of ovarian cancer
-
18:37
ongoing clinical trials with parp inhibitors in ovarian cancer
-
2:35
clinical use of niraparib in ovarian cancer
-
2:11
design of the nova trial for ovarian cancer
-
15:43
clinical data with parp inhibitors in ovarian cancer
-
1:42
final ananova2 survival data support niraparib plus bevacizumab in recurrent ovarian cancer
-
57:11
personalizing advanced ovarian cancer treatment with parp inhibitors and novel approaches
-
3:31
ongoing parp trials in recurrent ovarian cancer
-
3:11
rucaparib in recurrent ovarian cancer: ariel3 trial
-
7:30
parpi maintenance in hrd ovarian cancer: the prima trial
-
51:46
upgrading the treatment algorithm for advanced ovarian cancer
-
1:14
next steps for niraparib for ovarian cancer following on from the engot-ov16/nova trial